NCT05766839 - Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 6, 2025

Primary Completion Date

December 31, 2029

Study Completion Date

December 31, 2030

Conditions

Hyperkalemia

Interventions

DRUG

Patiromer

Patiromer will be given once daily; In Cohort 3, depending on the dose and the study participant's age, the total daily dose might be split

Trial Locations (12)

27710

RECRUITING

Duke University Hospital & Medical Center, Durham

31300

RECRUITING

Hôpital des Enfants - Toulouse, Toulouse

32207

RECRUITING

UF Health Pediatric Multispecialty Center, Jacksonville

33124

RECRUITING

Miller School of Medicine, University of Miami, Miami

34090

RECRUITING

CHRU Montpellier - Arnaud de Villeneuve, Montpellier

64108

RECRUITING

Children's Mercy Hospitals and Clinics, Kansas City

75019

RECRUITING

Assistance Publique-Hopitaux de Paris - Hopital Universitaire Robert-Debre, Paris

4920235

RECRUITING

Schneider Children's Medical Center of Israel, Petach Tikvah

9103102

RECRUITING

Shaare Zedek Medical Center, Jerusalem

Unknown

RECRUITING

Universitair Ziekenhuis Gent, Ghent

RECRUITING

Ippokratio Thessaloniki General Hospital, Thessaloniki

RECRUITING

Pan and Aglaia Kyriakou Children's Hospital, Athens

All Listed Sponsors

lead

Vifor Pharma, Inc.

INDUSTRY